Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · IEX Real-Time Price · USD
576.34
+1.75 (0.30%)
Apr 24, 2024, 3:40 PM EDT - Market open
Thermo Fisher Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 8,077 | 8,524 | 4,477 | 10,325 | 2,399 | 2,103 | 1,335 | 786 | 452.1 | 1,344 | Upgrade
|
| Cash & Cash Equivalents | 8,077 | 8,524 | 4,477 | 10,325 | 2,399 | 2,103 | 1,335 | 786 | 452.1 | 1,344 | Upgrade
|
| Cash Growth | -5.24% | 90.40% | -56.64% | 330.39% | 14.08% | 57.53% | 69.85% | 73.86% | -66.35% | -76.96% | Upgrade
|
| Receivables | 8,221 | 8,115 | 7,977 | 5,741 | 4,349 | 4,136 | 3,879 | 3,049 | 2,545 | 2,474 | Upgrade
|
| Inventory | 5,088 | 5,634 | 5,051 | 4,029 | 3,370 | 3,005 | 2,971 | 2,213 | 1,992 | 1,860 | Upgrade
|
| Other Current Assets | 3,203 | 2,956 | 2,608 | 1,862 | 1,775 | 1,381 | 1,236 | 973 | 752.5 | 863.2 | Upgrade
|
| Total Current Assets | 24,589 | 25,229 | 20,113 | 21,957 | 11,893 | 10,625 | 9,421 | 7,021 | 5,741 | 6,540 | Upgrade
|
| Property, Plant & Equipment | 9,448 | 9,280 | 8,333 | 5,912 | 4,749 | 4,165 | 4,047 | 2,578 | 2,449 | 2,427 | Upgrade
|
| Goodwill and Intangibles | 60,690 | 58,638 | 62,037 | 38,726 | 39,728 | 40,325 | 41,974 | 35,297 | 31,586 | 32,953 | Upgrade
|
| Other Long-Term Assets | 3,999 | 4,007 | 4,640 | 2,457 | 2,011 | 1,117 | 1,227 | 1,012 | 1,058 | 933.1 | Upgrade
|
| Total Long-Term Assets | 74,137 | 71,925 | 75,010 | 47,095 | 46,488 | 45,607 | 47,248 | 38,887 | 35,093 | 36,312 | Upgrade
|
| Total Assets | 98,726 | 97,154 | 95,123 | 69,052 | 58,381 | 56,232 | 56,669 | 45,908 | 40,834 | 42,852 | Upgrade
|
| Accounts Payable | 2,872 | 3,381 | 2,867 | 2,175 | 1,920 | 1,615 | 1,428 | 926 | 822.2 | 820.7 | Upgrade
|
| Deferred Revenue | 2,689 | 2,601 | 2,655 | 1,271 | 916 | 809 | 719 | 486 | 317.9 | 311.9 | Upgrade
|
| Current Debt | 3,609 | 5,579 | 2,537 | 2,628 | 676 | 1,271 | 2,135 | 1,255 | 1,052 | 2,212 | Upgrade
|
| Other Current Liabilities | 4,842 | 5,449 | 5,377 | 4,230 | 2,685 | 2,452 | 2,766 | 2,199 | 1,954 | 2,005 | Upgrade
|
| Total Current Liabilities | 14,012 | 17,010 | 13,436 | 10,304 | 6,197 | 6,147 | 7,048 | 4,866 | 4,146 | 5,350 | Upgrade
|
| Long-Term Debt | 31,308 | 28,909 | 32,333 | 19,107 | 17,076 | 17,719 | 18,873 | 15,372 | 11,420 | 12,352 | Upgrade
|
| Other Long-Term Liabilities | 6,682 | 7,203 | 8,499 | 5,124 | 5,433 | 4,780 | 5,335 | 4,130 | 3,918 | 4,603 | Upgrade
|
| Total Long-Term Liabilities | 37,990 | 36,112 | 40,832 | 24,231 | 22,509 | 22,499 | 24,208 | 19,502 | 15,338 | 16,954 | Upgrade
|
| Total Liabilities | 52,002 | 53,122 | 54,268 | 34,535 | 28,706 | 28,646 | 31,256 | 24,368 | 19,484 | 22,304 | Upgrade
|
| Total Debt | 34,917 | 34,488 | 34,870 | 21,735 | 17,752 | 18,990 | 21,008 | 16,627 | 12,472 | 14,564 | Upgrade
|
| Debt Growth | 1.24% | -1.10% | 60.43% | 22.44% | -6.52% | -9.61% | 26.35% | 33.31% | -14.36% | 38.87% | Upgrade
|
| Retained Earnings | 47,364 | 41,910 | 35,431 | 28,116 | 22,092 | 18,696 | 15,914 | 13,927 | 12,142 | 10,407 | Upgrade
|
| Comprehensive Income | -3,224 | -3,099 | -2,329 | -2,807 | -2,679 | -2,498 | -2,003 | -2,636 | -1,997.3 | -1,285 | Upgrade
|
| Shareholders' Equity | 46,735 | 43,978 | 40,793 | 34,507 | 29,675 | 27,586 | 25,413 | 21,540 | 21,350 | 20,548 | Upgrade
|
| Net Cash / Debt | -26,840 | -25,964 | -30,393 | -11,410 | -15,353 | -16,887 | -19,673 | -15,841 | -12,019.9 | -13,220.5 | Upgrade
|
| Net Cash Per Share | -69.18 | -65.90 | -76.56 | -28.60 | -38.10 | -41.59 | -49.43 | -39.90 | -29.90 | -32.86 | Upgrade
|
| Working Capital | 10,577 | 8,219 | 6,677 | 11,653 | 5,696 | 4,478 | 2,373 | 2,155 | 1,595 | 1,190 | Upgrade
|
| Book Value Per Share | 121.08 | 112.19 | 103.54 | 87.14 | 74.19 | 68.62 | 64.34 | 54.53 | 53.51 | 51.60 | Upgrade
|